Biggest News Aggregation in the World
๐Ÿ“ฐ Kumar Budur News

Page 3 - Kumar Budur News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Kumar Budur. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

HARMONY BIOSCIENCES ANNOUNCES US FOOD & DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT FOR TREATMENT OF IDIOPATHIC HYPERSOMNIA

PLYMOUTH MEETING, Pa., Sept. 7, 2023 /PRNewswire/ --ย Harmony Biosciences Holdings, Inc. , a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients...
Kumar Budur Luis Sanay Drug Administration Paragon Biosciences Harmony Biosciences Holdings Inc Exchange Commission

Harmony Biosciences Up 4% On Securing FDA Orphan Drug Designation For Pitolisant

Shares of Harmony Biosciences Holdings, Inc. (HRMY) are up 4% on Thursday after the company's Pitolisant Tablets was granted FDA Orphan Drug designation for the treatment of idiopathic hypersomnia (IH), a rare and chronic neurological disease that is characterized by excessive daytime sleepiness.
Kumar Budur Harmony Biosciences Holdings Inc Harmony Biosciences Holdings Pitolisant Tablets Chief Medical Officer Orphan Drug Designation

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q2 2023 Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q2 2023 Earnings Call Transcript August 1, 2023 Harmony Biosciences Holdings, Inc. misses on earnings expectations. Reported EPS is $0.57 EPS, expectations were $0.63. Operator: Good morning. My name is Todd, and I will be your conference operator today. At this time, I would like to welcome everyone to Harmony […]
United States Kumar Budur Jeffrey Dayno Sandip Kapadia Chief Medical Officer Prader Willi Syndrome
Source: yahoo.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science